Literature DB >> 11848461

Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein.

Shuichi Horie1, Sayuri Hiraishi, Tsutomu Hamuro, Yu-ichi Kamikubo, Juzo Matsuda.   

Abstract

Tissue factor pathway inhibitor (TFPI) is a physiological protease inhibitor of the extrinsic blood coagulation pathway. Previously we have shown that TFPI associates quite rapidly with oxidized low-density lipoprotein (ox-LDL), with a reduction of the inhibitory activity on factor X activation. In the present study, it was found, by means of agarose gel electrophoresis, that the pre-incubation of full-length rTFPI with heparin or the carboxy (C)-terminal part (peptide 240-265) of TFPI prevented the association with ox-LDL in a dose-dependent manner. When rTFPI lacking the C-terminal basic part of the molecule (rTFPI-C) was mixed with ox-LDL, only a small amount of rTFPI-C was shifted to the position of ox-LDL on electrophoresis. Further, ox-LDL did not reduce the activity of rTFPI-C. These results indicate that the C-terminal domain of TFPI molecule plays a predominant role in the binding to ox-LDL and the binding through the C-terminal part is essential for the ox-LDL-dependent reduction of the anticoagulant activity of TFPI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848461

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

Authors:  Xin Huang; Baoxin Liu; Yidong Wei; Ryan Beyea; Han Yan; Steven T Olson
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

Review 2.  Interdependent biological systems, multi-functional molecules: the evolving role of tissue factor pathway inhibitor beyond anti-coagulation.

Authors:  Eric W Holroyd; Robert D Simari
Journal:  Thromb Res       Date:  2010-02-24       Impact factor: 3.944

3.  Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development.

Authors:  Shuchong Pan; Thomas A White; Tyra A Witt; Anca Chiriac; Cheri S Mueske; Robert D Simari
Journal:  Circ Res       Date:  2009-08-27       Impact factor: 17.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.